(CAH) Cardinal Health - Ratings and Ratios

Cardinal Health Inc (NYSE:CAH) is a leading healthcare services and products company with operations spanning the United States, Canada, Europe, Asia, and other international markets. The company specializes in providing tailored solutions to a diverse range of healthcare entities, including hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and home healthcare settings. Organized into two primary segments—Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution—Cardinal Health offers a comprehensive suite of products and services. These include the distribution of branded, generic, and specialty pharmaceuticals, over-the-counter healthcare products, and medical supplies. Additionally, the company provides specialized services such as pharmacy management for hospitals, operation of community health center pharmacies, and repackaging of generic pharmaceuticals and over-the-counter products. Cardinal Health also manufactures and distributes a wide array of medical, surgical, and laboratory products under its own brand, including exam and surgical gloves, sharps disposal systems, wound care products, and surgical drapes. Furthermore, the company distributes national brand products, offers supply chain solutions, and assembles procedure kits for various healthcare providers. Cardinal Health also engages in the manufacture, preparation, and distribution of radiopharmaceuticals and related treatments, leveraging technology to optimize direct shipments. Established in 1979, the company is headquartered in Dublin, Ohio, and operates through a robust network that supports healthcare providers worldwide.

Cardinal Health Inc (NYSE:CAH) is forecasted to experience continued growth over the next three months, supported by its strong market position and diversified product offerings. Based on the technical data, the stock has shown resilience, trading above its 20-day and 50-day simple moving averages (SMA), which currently stand at 133.08 and 129.54, respectively. The 200-day SMA of 116.33 indicates a positive long-term trend, suggesting sustained upward momentum. The average true range (ATR) of 3.62 reflects moderate volatility, which may present opportunities for short-term traders. On the fundamental side, the companys market capitalization of $31.8 billion underscores its stability and scale. While the trailing P/E of 24.49 may indicate a premium valuation, the forward P/E of 14.64 suggests investor confidence in future earnings growth. The price-to-book (P/B) ratio of 16.07 highlights a rich valuation relative to book value, while the price-to-sales (P/S) ratio of 0.14 indicates efficient revenue generation. Despite a negative return on equity (RoE) of -43.80, which raises concerns about profitability, Cardinal Healths diversified business model and critical role in the healthcare supply chain position it for steady performance. Over the next quarter, the stock is likely to maintain its upward trajectory, driven by solid fundamentals and consistent execution, though investors should monitor valuation metrics and profitability trends.